Federal Register / Vol. 83, No. 150 / Friday, August 3, 2018 / Notices 38157 

TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity Number of 

respondents 

Number of 

responses per 

respondent 

Total 

annual 

responses 

Number of 

non-respondents 

Number of 

responses per 

non-respondent 

Total 

annual 

non-responses 

Average 

burden per 

response 

Total hours 

2019–2020 Data Collection 

(Healthcare Facilities)— 

Completion of Sections 1 

and 3.

400 1 400 ............................ .......................... ........................ 2.5 ..................... 1,000 

2019–2020 Data Collection 

(Schools)—Completion of 

Sections 1 and 3.

400 1 400 ............................ .......................... ........................ 2 ........................ 800 

2019–2020 Data Collection 

(Retail Food Stores)—Completion of Sections 1 and 3.

400 1 400 ............................ .......................... ........................ 3 ........................ 1,200 

2019–2020 Data CollectionCompletion of Section 2—All 

Facility Types.

1,200 1 1,200 ............................ .......................... ........................ 0.5 (30 minutes) 600 

2019–2020 Data CollectionEntry Refusals—All Facility 

Types.

.................... ........................ .................. 24 1 24 0.08 (5 minutes) 1.92 

Total ................................. .................... ........................ .................. ............................ .......................... ........................ ........................... 3,601.92 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

The burden for this information 

collection has not changed since the last 

OMB approval. 

II. References 

The following references are on 

display in the Dockets Management 

Staff (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane Rm. 

1061, Rockville, MD 20852, and are 

available for viewing by interested 

persons between 9 a.m. and 4 p.m., 

Monday through Friday; they are also 

available electronically at https://

www.regulations.gov. FDA has verified 

the website addresses, as of the date this 

document publishes in the Federal 

Register, but websites are subject to 

change over time. 

1. ‘‘Report of the FDA Retail Food Program 

Database of Foodborne Illness Risk Factors’’ 

(2000). Available at: https://wayback.archiveit.org/7993/20170406023019/https://www.

fda.gov/downloads/Food/Guidance

Regulation/UCM123546.pdf. 

2. ‘‘FDA Report on the Occurrence of 

Foodborne Illness Risk Factors in Selected 

Institutional Foodservice, Restaurant, and 

Retail Food Store Facility Types’’ (2004). 

Available at: https://wayback.archive-it.org/ 

7993/20170406023011/https://www.fda.gov/ 

downloads/Food/GuidanceRegulation/Retail

FoodProtection/FoodborneIllnessRiskFactor

Reduction/UCM423850.pdf. 

3. ‘‘FDA Report on the Occurrence of 

Foodborne Illness Risk Factors in Selected 

Institutional Foodservice, Restaurant, and 

Retail Food Store Facility Types’’ (2009). 

Available at: https://wayback.archive-it.org/ 

7993/20170406023004/https://www.fda.gov/ 

Food/GuidanceRegulation/RetailFood

Protection/FoodborneIllnessRiskFactor

Reduction/ucm224321.htm. 

4. FDA National Retail Food Team. ‘‘FDA 

Trend Analysis Report on the Occurrence of 

Foodborne Illness Risk Factors in Selected 

Institutional Foodservice, Restaurant, and 

Retail Food Store Facility Types (1998– 

2008).’’ Available at: https://wayback.

archive-it.org/7993/20170406022950/https://

www.fda.gov/Food/GuidanceRegulation/ 

RetailFoodProtection/FoodborneIllnessRisk

FactorReduction/ucm223293.htm. 

5. ‘‘FDA Food Code.’’ Available at:https:// 

www.fda.gov/Food/GuidanceRegulation/ 

RetailFoodProtection/FoodCode/default.htm. 

Dated: July 24, 2018. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2018–16648 Filed 8–2–18; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Committee on 

Interdisciplinary, Community-Based 

Linkages 

AGENCY: Health Resources and Service 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Advisory Committee on 

Interdisciplinary, Community-Based 

Linkages (ACICBL) has scheduled a 

public meeting. Information about 

ACICBL and the agenda for this meeting 

can be found on the ACICBL website at: 

https://www.hrsa.gov/advisorycommittees/interdisciplinarycommunity-linkages/index.html. 

DATES: August 16, 2018, 8:00 a.m.–2:00 

p.m. ET. 

ADDRESSES: This meeting will be held 

by teleconference and webinar. 

• Webinar link: https://

hrsa.connectsolutions.com/acicbl. 

• Conference call-in number: 1–800– 

324–5531; Passcode: 388458. 

FOR FURTHER INFORMATION CONTACT: Joan 

Weiss, Ph.D., RN, CRNP, FAAN, Senior 

Advisor and Designated Federal Official 

(DFO), at Division of Medicine and 

Dentistry, HRSA, 5600 Fishers Lane, 

Room 15N39, Rockville, Maryland 

20857; 301–443–0430; or jweiss@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACICBL 

provides advice and recommendations 

to the Secretary of HHS and to Congress 

on a broad range of issues relating to 

grant programs authorized by sections 

750–760, Title VII, Part D of the Public 

Health Service Act. During the August 

16, 2018, meeting, ACICBL members 

will discuss preparing the current and 

future healthcare workforce to practice 

in age-friendly health systems within 

the context of the quadruple aim. The 

quadruple aim focuses on enhancing the 

patient experience, improving 

population health, and reducing costs 

while improving the work life of health 

care providers, including clinicians and 

staff. ACICBL submits reports to the 

Secretary of HHS, the Committee on 

Health, Education, Labor, and Pensions 

of the Senate, and the Committee on 

Energy and Commerce of the House of 

Representatives. An agenda will be 

posted on the ACICBL website prior to 

the meeting. Agenda items are subject to 

change as priorities dictate. 

Members of the public will have the 

opportunity to provide comments. Oral 

comments will be honored in the order 

they are requested and may be limited 

as time allows. Requests to submit a 

written statement or make oral 

comments to ACICBL should be sent to 

Dr. Joan Weiss, DFO, using the contact 

information above at least 3 business 

days prior to the meeting. Individuals 

who plan to attend and need special 

assistance or another reasonable 

accommodation should notify Dr. Joan 

Weiss at the address and phone number 


amozie on DSK3GDR082PROD with NOTICES1
38158 Federal Register / Vol. 83, No. 150 / Friday, August 3, 2018 / Notices 

listed above at least 10 business days 

prior to the meeting. 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–16671 Filed 8–2–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Chemosensory Systems. 

Date: August 1, 2018. 

Time: 2:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1766, bennettc3@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 30, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16591 Filed 8–2–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–17– 

340: Collaborative Program Grant for 

Multidisciplinary Teams. 

Date: August 6, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and Related Research. 

Date: August 8, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and AIDS Related Research. 

Date: August 9, 2018. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurotoxicology and Alcohol. 

Date: August 9, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1766, bennettc3@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: AIDS and Related Research. 

Date: August 13, 2018. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: July 30, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16590 Filed 8–2–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


amozie on DSK3GDR082PROD with NOTICES1